CoChat

Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

Tardif, Jean-Claude, Rhéaume, Eric, Lemieux Perreault, Louis-Philippe, Grégoire, Jean C., Feroz Zada, Yassamin, Asselin, Géraldine, Provost, Sylvie, Barhdadi, Amina, Rhainds, David, L’Allier, Philippe L., Ibrahim, Reda, Upmanyu, Ruchi, Niesor, Eric J., Benghozi, Renée, Suchankova, Gabriela, Laghrissi-Thode, Fouzia, Guertin, Marie-Claude, Olsson, Anders G., Mongrain, Ian, Schwartz, Gregory G., Dubé, Marie-Pierre · 2015 · Circulation: Cardiovascular Genetics
Cited by 185

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background—: Dalcetrapib did not improve clinical outcomes, despite increasing high-density lipoprotein cholesterol by 30%. These results differ from other evidence supporting high-density lipoprotein as a therapeutic target. Responses to dalcetrapib may vary according to patients’ genetic profile. Methods and Results—: We conducted a pharmacogenomic evaluation using a genome-wide approach in the dal-OUTCOMES study (discovery cohort, n=5749) and a targeted genotyping panel in the dal-PLAQUE-2 imaging trial (support cohort, n=386). The primary endpoint for the discovery cohort was a composite of cardiovascular events. The change from baseline in carotid intima-media thickness on ultrasonography at 6 and 12 months was evaluated as supporting evidence. A single-nucleotide polymorphism was found to be associated with cardiovascular events in the dalcetrapib arm, identifying the ADCY9 gene on chromosome 16 (rs1967309; P =2.41×10 –8 ), with 8 polymorphisms providing P <10 –6 in this gene. Considering patients with genotype AA at rs1967309, there was a 39% reduction in the composite cardiovascular endpoint with dalcetrapib compared with placebo (hazard ratio, 0.61; 95% confidence interval, 0.41–0.92). In patients with genotype GG, there was a 27% increase in events with dalcetrapib versus placebo. Ten single-nucleotide polymorphism in the ADCY9 gene, the majority in linkage disequilibrium with rs1967309, were associated with the effect of dalcetrapib on intima-media thickness ( P <0.05). Marker rs2238448 in ADCY9 , in linkage disequilibrium with rs1967309 ( r 2 =0.8), was associated with both the effects of dalcetrapib on intima-media thickness in dal-PLAQUE-2 ( P =0.009) and events in dal-OUTCOMES ( P =8.88×10 –8 ; hazard ratio, 0.67; 95% confidence interval, 0.58–0.78). Conclusions—: The effects of dalcetrapib on atherosclerotic outcomes are determined by correlated polymorphisms in the ADCY9 gene. Clinical Trial Information—: URL: http://www.clinicaltrials.gov . Unique identifiers: NCT00658515 and NCT01059682

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circgenetics.114.000663

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 185

Metadata

Authors
Tardif, J.-C., Rhéaume, E., Lemieux Perreault, L.-P., Grégoire, J. C., Feroz Zada, Y., Asselin, G., Provost, S., Barhdadi, A., Rhainds, D., L’Allier, P. L., Ibrahim, R., Upmanyu, R., Niesor, E. J., Benghozi, R., Suchankova, G., Laghrissi-Thode, F., Guertin, M.-C., Olsson, A. G., Mongrain, I., Schwartz, G. G., & Dubé, M.-P.
Venue
Circulation: Cardiovascular Genetics
Published
2015-04
Volume
8
Issue
2
Pages
372-382
ISSN
  • 1942-325X (ISSN-L)
  • 1942-3268
OpenAlex
W2099697702
Cited by
185
References
9
FWCI
27.87
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib. https://app.cochat.ai/papers/10.1161/circgenetics.114.000663
The paper
Tardif, J.-C., Rhéaume, E., Lemieux Perreault, L.-P., Grégoire, J. C., Feroz Zada, Y., Asselin, G., Provost, S., Barhdadi, A., Rhainds, D., L’Allier, P. L., Ibrahim, R., Upmanyu, R., Niesor, E. J., Benghozi, R., Suchankova, G., Laghrissi-Thode, F., Guertin, M.-C., Olsson, A. G., Mongrain, I., . . . Dubé, M.-P. (2015). Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib. Circulation: Cardiovascular Genetics. https://doi.org/10.1161/circgenetics.114.000663

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.